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Background: Involuntary medication in psychiatric treatment of inpatients is highly con-
troversial. While laws regulating involuntary medication have been changed in Germany, 
no data have been available to date on how often involuntary medication is actually 
applied. Recently, our hospital group introduced specific routine documentation of legal 
status and application of involuntary medication in the patients’ electronic records, which 
allows the assessment of the frequency of involuntary medication.
Method: For the year 2014, we extracted aggregated data from the electronic data-
base on age, sex, psychiatric diagnosis, legal status during admission, kind of coercive 
measure (mechanical restraint, seclusion, and involuntary medication) applied, and the 
number and duration of seclusion and restraint episodes for seven study sites.
results: A total of 1,514 (9.6%) of 15,832 admissions were involuntary. At least one 
coercive measure was applied in 976 (6.2%) admissions. Seclusion was applied in 579 
(3.7%) admissions, mechanical restraint was applied in 529 (3.3%) admissions, and 
involuntary medication was applied in 78 (0.5%) admissions. Two-thirds of involuntary 
medications were applied in cases of emergency; the remainder was applied after a 
formal decision by a judge. In 55 (70.5%) of the admissions with involuntary medication, 
at least one other coercive measure (seclusion, restraint, or both) was applied as well.
conclusion: Involuntary medication is rarely applied and less frequent than seclusion or 
mechanical restraint, possibly as a consequence of recent legal restrictions.
Keywords: coercion, seclusion, restraint, physical, forced medication, involuntary treatment
inTrODUcTiOn
The UN Convention on the Rights of Persons with Disabilities (UN-CRPD) (1) was adopted by the 
United Nations General Assembly in 2006 and has been ratified by 159 states to date (2). Its purpose 
is “to promote, protect, and ensure full and equal enjoyment of all human rights and fundamental 
freedoms by all people with disabilities” (1). According to article 1 of the CRPD, it is fully applicable 
to the situation of people with mental disorders. Article 12 states that “persons with disabilities enjoy 
legal capacity on an equal basis with others in all aspects of life” (1). The Committee on the Rights of 
Persons with Disabilities, the body competent to monitor the implementation of the CRPD, makes 
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clear that supported decision-making, involuntary admissions to 
mental health facilities and forced mental health treatment are 
inacceptable (3). Although the purpose of the CRPD is unques-
tioned, there is some concern that its impact might be paradoxical 
and violate several fundamental rights (4). In its statement to the 
demands of the Committee, the German government argues that 
the main problems of people with disabilities concerning legal 
capacity are not due to laws regulating guardianship themselves 
but rather to their practical realization (5).
In Germany, coercive interventions in psychiatry are regulated 
through the laws of guardianship (Betreuungsrecht), which, 
as federal law, is valid everywhere in the country and in public 
laws (comparable to mental health acts in other countries), with 
slightly different regulations in the 16 German federal states 
(Bundesländer) [“Psych-KG,” “Unterbringungsgesetz” (Law on 
Compulsory Hospitalization)]. For about a decade, involved 
stakeholders have expected that it would be necessary to consider 
involuntary admission and involuntary treatment separately in law 
texts as some European countries and the United States have done 
since 1980. This happened in 2011 when the Constitutional Court 
(Bundesverfassungsgericht) ruled on two decisions concerning 
involuntary medication in forensic psychiatry, which had a huge 
impact on clinical practice. In both cases, the Constitutional 
Court decided the existing laws regulating involuntary medica-
tion were unconstitutional and, thus, were no longer valid. The 
Constitutional Court determined that law texts should clarify 
that involuntary medication could be applied only for people 
without capacity to consent, and only as a last measure if all other 
approaches had failed, particularly after intensive attempts to 
convince the patient. Moreover, this should be allowed only after 
a separate court decision, and taking into account the review of an 
independent expert. Though this decision was primarily related 
to forensic psychiatry, other supreme courts (Bundesgerichtshof) 
adopted this view and extended it to all kinds of involuntary 
treatment, including that given to general psychiatric patients. 
Consequently, involuntary medication was no longer a legitimate 
means of psychiatric treatment, except for acute emergencies, until 
new legislations fulfilling the Constitutional Court’s requirements 
were adopted in 2013. This referred to guardianship law as well.
These changes in legislation and jurisdiction have caused 
intense discussions among psychiatrists, patients’ organiza-
tions, ethical boards, jurists, and political stakeholders. 
Although many statements have been published, such as 
ones from the German Association for Psychiatry and 
Psychotherapy and the ethical committee of the Federal 
Chamber of Physicians, among others, no data are currently 
available to show how often involuntary medication really 
happens. Due to the lack of clear definition and defined legal 
procedures, no statistics had been collected. The same applies 
to most other countries. In 2013, our hospital group introduced 
specific routine documentation of legal status and application 
of involuntary medication in the patients’ electronic records. 
Thus, data on the use of coercive medication in psychiatric 
hospitals in Germany are available for the first time, subdivided 
according to the respective legal basis. Furthermore, because 
reliable data on freedom-restricting coercive measures, such as 
seclusion and mechanical restraint is also available, according 
to a thoroughly implemented routine documentation, the fre-
quency of coercive medication can be related to the frequency 
of freedom-restrictive interventions.
MaTerials anD MeThODs
study sites
The Centers for Psychiatry Suedwuerttemberg are a psychiatric 
organization providing inpatient and outpatient mental health 
care and serving a catchment area of about 1.2 million inhabit-
ants in southwest Germany. The seven psychiatric inpatient units 
are four psychiatric hospitals and three psychiatric departments 
of general hospitals with a total of about 1,100 beds and 15,000 
admissions per year. All of them are responsible for a defined 
catchment area, including all involuntary admissions. The num-
ber of beds amounts to ~93/100,000 inhabitants. Although no 
other psychiatric inpatient units are available in the respective 
areas, alternatives to inpatient treatment exist with day clinics, 
outpatient units and highly developed community services, 
including home treatment.
Data sources
The centers operate an extensive electronic database of routinely 
collected clinical information from basic patient documentation 
[Basisdokumentation (BADO)]. The database also contains 
information on the use of seclusion and restraint, including exact 
data on the duration of each measure and is collected according to 
clear definitions (6). These data can be considered highly accurate 
due to the legal obligations of documentation. In general, the 
patient characteristics of the BADO documented in the electronic 
charts is sufficiently valid and reliable (7).
For the year 2014, we extracted the following aggregated 
data from all hospital admissions in the seven hospitals that 
existed in the electronic database: age, sex, psychiatric diagnosis 
according to ICD-10, legal status during admission (whether 
voluntary or detained according to guardianship legislation or 
whether detained, according to mental health legislation), kind 
of coercive measure (if it occurred: mechanical restraint, seclu-
sion, or involuntary medication as either an emergency measure 
or involuntary medication after judge’s decision), number of 
coercive measures per admission, and the duration of mechanical 
restraint or seclusion. Thus, all presented data refer to admissions, 
not to patients; the number of patients is lower than the number 
of admissions due to readmissions.
Definitions
Admissions were classified as “involuntary” if patients stayed 
involuntarily in the hospital at any time. This included all cases 
with court decisions on involuntary commitment but also those 
in which patients changed their mind after a short time and 
subsequently stayed on a voluntary basis before application to a 
court.
Seclusion is defined as bringing the patient into a locked room 
where he or she is alone and able to move freely but unable to 
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leave due to a locked door (8). During seclusion, patients are 
observed through a window in the door of the seclusion room or 
by video monitoring.
Mechanical restraint refers to the use of belts to fix the patient 
to the bed (8). According to internal hospital guidelines, patients 
have to be constantly and personally monitored during mechani-
cal restraint.
Involuntary medication is defined according to an agreement 
of the German working groups on violence and coercion as any 
medication, oral or per injection, against the patient’s explicit 
or implicit will (9). In the ambiguous area of psychological 
pressure, medication is classified as “involuntary,” if patients 
have no other choice than being subjected to a different kind of 
coercive measure if they would refuse medication. Two types of 
involuntary medication can be distinguished, according to the 
current legal situation. Involuntary medication can be applied in 
case of acute emergency if required to prevent serious harm (in 
this case, the physician remains free of punishment according to 
the penalty law, although no special legal basis exists). The other 
case for involuntary medication is after a judge’s decision based 
on an independent expert’s review, which can occur as a matter 
of guardianship law as well as public law.
ethical considerations
Privacy of patients and confidentially of personal information was 
ensured by using solely aggregated data (e.g., absolute numbers, 
means, and proportions) but not identifiable individual data. 
As retrospective, aggregated data from electronic databases was 
used, ethical committee approval was not considered necessary 
according to German regulations.
resUlTs
The sample consisted of 15,832 admissions (7,656 women, 48.4%). 
The mean age was 45.9  years (SD =  18.8), for women it was 
47.9 (SD = 19.2) and for men 43.7 (SD = 18.1). The admissions 
totaled over 10,181 patients (4,995 women, 49.1%). Of the 15,832 
TaBle 1 | Main diagnoses (icD-10) and length of stay according to legal status.
Main diagnosis 
(icD-10)
legal statusa Total (N = 15,832)
Voluntary (n = 14,318) Detained according to mental  
health legislation (n = 1,026)
Detained according to guardianship 
legislation (n = 488)
F0/G3 965 (6.7%) 136 (13.3%) 146 (29.9%) 1,247 (7.9%)
F1 4,544 (31.7%) 282 (27.5%) 60 (12.3%) 4,886 (30.9%)
F2 2,050 (14.3%) 383 (37.3%) 194 (39.8%) 2,627 (16.6%)
F3 3,724 (26.0%) 96 (9.4%) 25 (5.1%) 3,845 (24.3%)
F4 1,895 (13.2%) 77 (7.5%) 32 (6.6%) 2,004 (12.7%)
F5 52 (0.4%) 0 (0.0%) 0 (0.0%) 52 (0.3%)
F6 795 (5.6%) 51 (5.0%) 18 (3.7%) 864 (5.5%)
F9 293 (2.0%) 1 (0.1%) 13 (2.7%) 307 (1.9%)
Length of stay 
(days; mean, SD)
26.7 (26.9) 30.5 (40.9) 47.4 (53.1) 27.6 (29.3)
aAll percentages reflect the proportion of the column total.
admissions, 1,514 (9.6%) of them were involuntary: 1,026 (6.5%) 
of these were admitted according to mental health legislation and 
488 (3.1%) were admitted according to guardianship legislation. 
Table 1 shows the main diagnoses (ICD-10) and the length of stay 
according to the legal status of admission.
At least one coercive measure was applied in 976 admissions 
(6.2%) of which 424 were women (43.4%). The number and the 
duration of each kind of coercive intervention and the percentage 
of affected admissions according to legal status are presented in 
Table 2.
The most frequent main diagnosis among those admissions 
was schizophrenia, schizotypal, or delusional disorder (ICD-10 
F2, 393 admissions, 40.3%). The number of affected cases for each 
main diagnosis is presented in Table  3. Seclusion was applied 
in 579 admissions (3.7%) and 529 admissions (3.3%) received 
mechanical restraint. The total number of seclusions was 3,016 
(5.2 measures per affected admission), and the total number of 
mechanical restraints was 1,962 (3.7 measures per affected admis-
sion). The mean duration of seclusion was 5.5 h (SD = 7.9), and 
the mean duration of mechanical restraint was 8.1 h (SD = 7.2). 
Involuntary medication was applied in 78 admissions (0.5%). 
Among the admissions with involuntary medication the main 
diagnosis of schizophrenia, schizotypal, or delusional disorder 
(ICD-10 F2) was most frequent (57 admissions, 73.1%). In 55 
(70.5%) of those admissions affected by involuntary medication 
at least one other coercive measure (seclusion, restraint, or both) 
was applied as well.
DiscUssiOn
This is the first data on the use of coercive medication in Germany 
since the introduction of the legislation increased the threshold 
for the application of such measures in 2013. These results from 
seven psychiatric departments and hospitals in Germany show 
that 6% of over 15,000 admissions in 2014 were subjected to 
some kind of coercive measures. Involuntary medication was 
applied in less than a tenth (0.5%) of those cases. Two-thirds 
of coercive medications were applied in cases of emergency; 
TaBle 3 | cases with coercive measures according to main diagnosis.
Main diagnosis (icD-10) coercive measurea Totalb
seclusion Mechanical 
restraint
involuntary medication as an 
emergency measure
involuntary medication 
after judge’s decision
F0/G3 (n = 1,247) 55 (4.4%) 146 (11.7%) 13 (1.0%) 1 (0.1%) 196 (15.7%)
F1 (n = 4,886) 77 (1.6%) 95 (1.9%) 2 (0.0%) 1 (0.0%) 163 (3.3%)
F2 (n = 2,627) 279 (10.6%) 187 (7.1%) 40 (1.5%) 26 (1.0%) 393 (15.0%)
F3 (n = 3,845) 43 (1.1%) 36 (0.9%) 2 (0.1%) 1 (0.0%) 66 (1.7%)
F4 (n = 2,004) 48 (2.4%) 15 (0.7%) 1 (0.0%) 0 (0.0%) 58 (2.9%)
F5 (n = 52) 1 (1.9%) 1 (1.9%) 0 (0.0%) 0 (0.0%) 1 (1.9%)
F6 (n = 864) 65 (7.5%) 46 (5.3%) 2 (0.2%) 0 (0.0%) 87 10.1(%)
F9 (n = 307) 11 (3.6%) 3 (1.0%) 0 (0.0%) 0 (0.0%) 12 (3.9%)
aAll percentages reflect the proportion of the row total.
bAdmissions who suffered more than one coercive measure are only totaled once.
TaBle 2 | affected cases, number, and duration of coercive measures according to legal status.
legal status coercive measurea Totalb
seclusion Mechanical 
restraint
involuntary medication as  
an emergency measure
involuntary medication after 
judge’s decision
Voluntary (n = 14,318) 263 (1.8%) 228 (1.6%) 12 (0.1%) 0 (0.0%) 455 (3.2%)
Detained according to mental health 
legislation (n = 1,026)
187 (18.2%) 220 (21.4%) 31 (3.0%) 17 (1.7%) 347 
(33.8%)
Detained according to guardianship 
legislation (n = 488)
129 (26.4%) 81 (16.6%) 17 (3.5%) 12 (2.5%) 174 
(35.7%)
Total (N = 15,832) 579 (3.7%) 529 (3.3%) 60 (0.4%) 29 (0.2%) 976 (6.2%)
Number of coercive measures 3,016 1,962 5,125
Duration (h; mean, SD) 5.5 (7.9) 8.1 (7.2) 6.5 (7.7)
aAll percentages reflect the proportion of the row total.
bAdmissions who suffered more than one coercive measure are only totaled once.
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only 0.2% of admissions received involuntary medication after 
a judge’s decision. Because data on the previous practice are 
only scarcely available, it is difficult to say whether the percent-
age of exposed patients has decreased after the introduction of 
the legislation. Estimations of percentage of affected patients 
vary between 0.4 and 5.6% (10–12). According to these data, 
there is some uncertain evidence that the use of involuntary 
medication has considerably decreased after the introduction 
of the legislation, which had been intended. However, a dif-
ferent question is whether this is good news for patients. In a 
previous analysis, we found a doubling of the numbers of seclu-
sion and restraint and of patient assaults on staff during the 
temporary lack of admissibility of involuntary medication due 
to a gap in legislation for some months between 2012 and 2013 
(13). While the threshold for involuntary medication has been 
increased in Germany in recent years, the Netherlands went the 
opposite way after realizing that a restriction of medication had 
led to a dramatic increase in the use of seclusion and in patient 
assaults (14, 15). Recently, evidence has become available that 
those hospitals using less medication use more seclusion and 
vice  versa (16). However, data after a policy change in New 
York concerning unscheduled psychotropic medication for 
agitation in an acute psychiatric inpatient setting indicate that 
a reduction in medication does not necessarily derogate safety 
(17). While PRN (pro re nata, i.e., “as needed”) medication 
decreased significantly after a mandated change in utilization, 
there was no significant difference in rates of assault or seclusion 
7.5 months before and after that policy change. In the course 
of an overlapping hospital project that aimed to reduce the use 
of restraints, the restraint rate significantly decreased over the 
period of review.
So, further developments should be observed carefully, which 
may possibly be helped by the introduction of a statewide register 
for coercive measures, as required by the new Mental Health Act 
(2015) in the state of Baden-Württemberg (18).
The most important limitation of the presented data is that 
it is grounded on a very limited number of hospitals. It remains 
unclear to which extent these data are representative of psychi-
atric hospitalization practices in Germany as a whole. Another 
concern might be that involuntary medication by definition did 
not include subtle forms of pressure on a patient to take medica-
tion which can be experienced as “coercive” without fulfilling 
formal criteria of coercion according to the definition applied 
(9). So from patient’s perspective, the finding that only one in 
200 patients received involuntary medication could be an under-
estimation of the real problem.
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